Prostate cancer that spreads or comes back after treatment is often small and hard to detect. A new test called a PSMA PET scan makes these tumors easier to spot. Learn more.

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed ...

PSMA therapy won’t cure prostate cancer, but it may ease symptoms, slow its growth, ... You’ll also have a PSMA PET scan that can spot cancer outside your prostate.

PSMA PET has set the stage for development of PSMA-based radioligand therapies such as lutetium-177-PSMA-617 (177 Lu-PSMA-617) that target and kill PSMA-expressing prostate cancer cells.

An expert discusses how CT scans and bone scans remain the standard imaging approach for most patients with metastatic castration-resistant prostate cancer (mCRPC), whereas prostate-specific membrane ...

How PSMA Lights Up Cancer Cells. In 2021, the U.S. Food and Drug Administration issued national approval to two new prostate cancer imaging tests based on similar technology. On a PET scan, the test ...

PSMA-PET leverages ‘radiotracers’ that bind to prostate cancer cells, making them visible on PET scans and providing functional imaging that reveals the biological activity of cancer.

I think we're in a very significant new era with regard to managing advanced prostate cancer. I think one of the most significant recent advances is the use of PSMA imaging, PET scan in particular.

Data analysis included 182 patients who had a median pre-scan PSA level of 2.6 ng/mL Overall, 84% of the patients had positive PSMA-PET/CT results, including 80% (73 of 91) after radical ...